• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠肺炎患者血清中数月来持续存在对 SARS-CoV-2 的中和活性。

Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.

机构信息

Paediatric Endocrinolgy, University Children's Hospital, Hoppe-Seyler-Str. 1, 72076 Tuebingen, Germany.

Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH, Aspenhaustr. 25, 72770 Reutlingen, Germany.

出版信息

Viruses. 2020 Nov 27;12(12):1357. doi: 10.3390/v12121357.

DOI:10.3390/v12121357
PMID:33260809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7761220/
Abstract

The relationship between the nasopharyngeal virus load, IgA and IgG antibodies to both the S1-RBD-protein and the N-protein, as well as the neutralizing activity (NAbs) against SARS-CoV-2 in the blood of moderately afflicted COVID-19 patients, needs further longitudinal investigation. Several new serological methods to examine these parameters were developed, validated and applied in three patients of a family which underwent an ambulatory course of COVID-19 for six months. The virus load had almost completely disappeared after about four weeks. Serum IgA levels to the S1-RBD-protein and, to a lesser extent, to the N-protein, peaked about three weeks after clinical disease onset but declined soon thereafter. IgG levels rose continuously, reaching a plateau at approximately six weeks, and stayed elevated over the observation period. Virus-neutralizing activity reached a peak about 4 weeks after disease onset but dropped slowly. The longitudinal associations of virus neutralization and the serological immune response suggest immunity in patients even after a mild clinical course of COVID-19.

摘要

中度感染 COVID-19 患者血液中的鼻咽病毒载量、针对 S1-RBD 蛋白和 N 蛋白的 IgA 和 IgG 抗体以及针对 SARS-CoV-2 的中和抗体(NAbs)之间的关系需要进一步进行纵向研究。为此,开发、验证并应用了几种新的血清学方法,以检查这几个参数,这些方法在经历了六个月门诊 COVID-19 病程的一个家庭中的三个患者中进行了应用。大约四周后,病毒载量几乎完全消失。针对 S1-RBD 蛋白的血清 IgA 水平,以及在较小程度上针对 N 蛋白的 IgA 水平,在临床发病后约三周达到峰值,但此后很快下降。IgG 水平持续上升,在大约六周时达到平台期,并在观察期间保持升高。病毒中和活性在发病后约 4 周达到峰值,但下降缓慢。病毒中和与血清免疫反应的纵向关联表明,即使在 COVID-19 轻度临床病程后,患者仍具有免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/7761220/5f05842b6895/viruses-12-01357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/7761220/25ebdf66cff8/viruses-12-01357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/7761220/5f05842b6895/viruses-12-01357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/7761220/25ebdf66cff8/viruses-12-01357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/092a/7761220/5f05842b6895/viruses-12-01357-g002.jpg

相似文献

1
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.新冠肺炎患者血清中数月来持续存在对 SARS-CoV-2 的中和活性。
Viruses. 2020 Nov 27;12(12):1357. doi: 10.3390/v12121357.
2
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征(MIS-C)中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
3
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
4
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.中国北京一家三级甲等医院中新冠病毒肺炎患者抗体反应的纵向分析
Front Immunol. 2021 Mar 15;12:614436. doi: 10.3389/fimmu.2021.614436. eCollection 2021.
5
Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.COVID-19 患者再次检测到病毒 RNA 阳性时存在低固有免疫和滞后适应性免疫反应。
Front Immunol. 2021 Jul 1;12:664619. doi: 10.3389/fimmu.2021.664619. eCollection 2021.
6
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.N 抗原和 S 抗原与 IgA 和 IgG 联合检测可提高 SARS-CoV-2 血清学诊断的准确性。
J Infect Dis. 2021 Jul 15;224(2):218-228. doi: 10.1093/infdis/jiab222.
7
Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples.新型冠状病毒肺炎患者和历史样本中针对 SARS-CoV-2 蛋白 N、S 和 E 的抗体。
J Gen Virol. 2021 Nov;102(11). doi: 10.1099/jgv.0.001692.
8
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.新型冠状病毒感染后长达13个月的抗体反应演变及再次感染风险。
EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27.
9
The kinetics of viral load and antibodies to SARS-CoV-2.病毒载量和 SARS-CoV-2 抗体的动力学。
Clin Microbiol Infect. 2020 Dec;26(12):1690.e1-1690.e4. doi: 10.1016/j.cmi.2020.08.043. Epub 2020 Sep 6.
10
Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).根据世界卫生组织国际结合抗体单位(BAU/mL),自然感染和随后接种疫苗后对 SARS-CoV-2 的长期体液免疫反应。
Viruses. 2021 Nov 23;13(12):2336. doi: 10.3390/v13122336.

引用本文的文献

1
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison.研究商业 SARS-CoV-2 检测试剂盒的时间效价演变揭示了使用 BAU 标准化进行比较的显著缺陷。
Virol J. 2023 Sep 1;20(1):200. doi: 10.1186/s12985-023-02167-z.
2
A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.针对 SARS-CoV-2 变异株设计的保守亚单位疫苗显示出中和该病毒的证据。
Appl Microbiol Biotechnol. 2022 Jun;106(11):4091-4114. doi: 10.1007/s00253-022-11988-x. Epub 2022 May 25.
3
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody.

本文引用的文献

1
IgA dominates the early neutralizing antibody response to SARS-CoV-2.IgA 在针对 SARS-CoV-2 的早期中和抗体反应中占主导地位。
Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abd2223. Epub 2020 Dec 7.
2
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
3
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.
评估用于预测高滴度严重急性呼吸综合征冠状病毒2中和抗体的自动化高通量血清学检测方法。
J Clin Virol Plus. 2021 Jun;1(1):100016. doi: 10.1016/j.jcvp.2021.100016. Epub 2021 May 4.
4
Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).根据世界卫生组织国际结合抗体单位(BAU/mL),自然感染和随后接种疫苗后对 SARS-CoV-2 的长期体液免疫反应。
Viruses. 2021 Nov 23;13(12):2336. doi: 10.3390/v13122336.
5
Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects' eligibility?康复期血浆捐献者对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗体反应:我们能否预测受试者的合格性?
Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):1-6. doi: 10.1016/j.htct.2021.07.008. Epub 2021 Nov 4.
6
Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.法国郊区人群中 SARS-CoV-2 血清流行率、症状谱和血清中和抗体情况
Viruses. 2021 Jun 4;13(6):1076. doi: 10.3390/v13061076.
7
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.接种疫苗人群对关注的 SARS-CoV-2 变异株的免疫应答
Nat Commun. 2021 May 25;12(1):3109. doi: 10.1038/s41467-021-23473-6.
8
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.日本综合医院和诊所医护人员中 SARS-CoV-2 的血清流行率。
Int J Environ Res Public Health. 2021 Apr 5;18(7):3786. doi: 10.3390/ijerph18073786.
9
[Biology and pathology of coronaviruses].[冠状病毒的生物学与病理学]
Pathologe. 2021 Mar;42(2):149-154. doi: 10.1007/s00292-021-00923-y. Epub 2021 Mar 1.
10
Anti-spike S1 receptor-binding domain antibodies against SARS-CoV-2 persist several months after infection regardless of disease severity.针对 SARS-CoV-2 的刺突蛋白 S1 受体结合域抗体在感染后持续存在数月,无论疾病严重程度如何。
J Med Virol. 2021 May;93(5):3158-3164. doi: 10.1002/jmv.26878. Epub 2021 Feb 23.
冠状病毒抗体介导免疫的系统评价:动力学、保护相关性及与严重程度的关系。
Nat Commun. 2020 Sep 17;11(1):4704. doi: 10.1038/s41467-020-18450-4.
4
Biochemical characterization of SARS-CoV-2 nucleocapsid protein.SARS-CoV-2 核衣壳蛋白的生化特性分析。
Biochem Biophys Res Commun. 2020 Jun 30;527(3):618-623. doi: 10.1016/j.bbrc.2020.04.136. Epub 2020 Apr 30.
5
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids.SARS-CoV-2 RNA 在体液中持续存在。
Emerg Infect Dis. 2020 Aug;26(8):1834-1838. doi: 10.3201/eid2608.201097. Epub 2020 May 8.
6
Telephonic triage before surgical ward admission and telemedicine during COVID-19 outbreak in Italy. Effective and easy procedures to reduce in-hospital positivity.意大利新冠疫情期间手术病房入院前的电话分诊及远程医疗。降低院内阳性率的有效且简便程序。
Int J Surg. 2020 Jun;78:123-125. doi: 10.1016/j.ijsu.2020.04.060. Epub 2020 May 1.
7
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入因子与固有免疫基因一起在鼻上皮细胞中高表达。
Nat Med. 2020 May;26(5):681-687. doi: 10.1038/s41591-020-0868-6. Epub 2020 Apr 23.
8
Temporal dynamics in viral shedding and transmissibility of COVID-19.新冠病毒脱落和传播的时间动态。
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
9
An Infectious cDNA Clone of SARS-CoV-2.严重急性呼吸综合征冠状病毒 2 的感染性 cDNA 克隆。
Cell Host Microbe. 2020 May 13;27(5):841-848.e3. doi: 10.1016/j.chom.2020.04.004. Epub 2020 Apr 13.
10
Household transmission of SARS-CoV-2.家庭传播的 SARS-CoV-2.
J Infect. 2020 Jul;81(1):179-182. doi: 10.1016/j.jinf.2020.03.040. Epub 2020 Apr 10.